A Study of Ivonescimab in Combination With Enfortumab Vedotin vs Pembrolizumab in Combination With Enfortumab Vedotin in Metastatic Urothelial Carcinoma | MicrobiomeTrials
A Study of Ivonescimab in Combination With Enfortumab Vedotin vs Pembrolizumab in Combination With Enfortumab Vedotin in Metastatic Urothelial Carcinoma
RecruitingPHASE2, PHASE3INTERVENTIONAL
Trial Details
Start: 2026-09-10Est. Completion: 2030-10-31
Enrollment target: 800 participants
Locations
Research Site, Phoenix, Arizona, United States
Research Site, Los Angeles, California, United States
Research Site, Washington D.C., District of Columbia, United States
Research Site, Jacksonville, Florida, United States
Research Site, Rochester, Minnesota, United States
Research Site, Nashville, Tennessee, United States